Dexcom Announces Partnership with Team Novo Nordisk

{
  "signal_id": "ae9472fd-ad42-167e-e8cd-59adde730622",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-10-03T08:06:09+00:00",
  "company": {
    "name": "Dexcom",
    "domain": "dexcom.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/dexcom-kuendigt-partnerschaft-mit-team-novo-nordisk-an/70219678",
    "title": "Dexcom Announces Partnership with Team Novo Nordisk - AD HOC NEWS",
    "excerpt": "On September 28, 2026, DexCom, Inc. announced a partnership with Team Novo Nordisk. The company also published a new report on the care of people with type 2 diabetes. Dexcom's announcement dates the announcement to September 28, 2026. On October 3, 2026, at 10:03 AM, the Dexcom share cost 76.20 Euros in weekend trading at Lang & Schwarz. This corresponds to an increase of 0.10 Euros or 0.13 percent compared to the closing price on October 2, 2026, at Lang & Schwarz of 76.10 Euros. The bid price was 76.00 Euros, the ask price was 76.40 Euros. The further development in weekend trading at Lang & Schwarz until 1:00 PM is shown by the continuously updated real-time price of the Dexcom share. Dexcom announced that it would become the official continuous glucose monitoring partner of Team Novo Nordisk. According to the company, the partnership aims to support research, education, and awareness of the importance of glucose data in people with type 1 diabetes. In the new \"State of Type 2 Report,\" Dexcom evaluated data from more than 800 healthcare professionals and 2,500 people with type 2 diabetes from eight countries. According to the results published by Dexcom, 55 percent of the surveyed people with type 2 diabetes stated that they had only limited knowledge of continuous glucose monitoring. The publication took place in the context of the annual meeting of the European...",
    "product": "State of Type 2 Report",
    "summary": "Dexcom published a new report, \"State of Type 2 Report,\" on the care of people with type 2 diabetes.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2697605_1920_1080.webp",
    "confidence": 0.8,
    "product_data": {
      "name": "State of Type 2 Report",
      "full_text": "new \"State of Type 2 Report,\"",
      "fuzzy_match": false
    },
    "product_tags": [
      "report",
      "medical"
    ],
    "published_at": "2026-10-03T08:06:09Z",
    "article_sentence": "The company also published a new report on the care of people with type 2 diabetes."
  }
}

curl https://signals.autobound.ai/v1/signals/ae9472fd-ad42-167e-e8cd-59adde730622 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"dexcom.com","limit":20}'